In 2005, after the identification of cardiovascular safety concerns with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), the FDA issued a black box warning recommending against the use of NSAIDs following cardiac surgery. The goal of this study was to assess the postoperative safety of ketorolac, an intravenously administered NSAID, after cardiac surgery.Retrospective observational study.Single center, regional hospital.A total of 1,309 cardiac surgical patients (78.1
作者:Lisa, Oliveri;Katie, Jerzewski;Alexander, Kulik
来源:Journal of cardiothoracic and vascular anesthesia 2014 年 28卷 2期